[1] |
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, patho⁃genesis, evaluation and prognosis[J]. Am J Dermatopathol, 2005, 27(6): 504⁃528. DOI: 10.1097/01.dad.0000181109.54532.c5.
|
[2] |
Ece A, Kelekçi S, Hekimoglu A, et al. Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch⁃Schönlein purpura[J]. Pediatr Nephrol, 2007, 22(8): 1151⁃1157. DOI: 10.1007/s00467⁃007⁃0475⁃5.
|
[3] |
Monteiro RC, Van De Winkel JG. IgA Fc receptors[J]. Annu Rev Immunol, 2003, 21: 177⁃204. DOI: 10.1146/annurev.immunol. 21.120601.141011.
|
[4] |
Ortiz⁃Sanjuán F, Blanco R, Hernández JL, et al. Applicability of the 2006 European League Against Rheumatism (EULAR) criteria for the classification of Henoch⁃Schönlein purpura. An analysis based on 766 patients with cutaneous vasculitis[J/OL]. Clin Exp Rheumatol, 2015, 33(2 Suppl 89): S⁃44⁃7[2017⁃06⁃10]. http://www.clinexprheumatol.org/abstract.asp?a=8633.
|
[5] |
Leung JC, Chan LY, Saleem MA, et al. Combined blockade of angiotensin Ⅱ and prorenin receptors ameliorates podocytic apoptosis induced by IgA⁃activated mesangial cells[J]. Apoptosis, 2015, 20(7): 907⁃920. DOI: 10.1007/s10495⁃015⁃1117⁃1.
|
[6] |
Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade[J]. Science, 1994, 265(5175): 1095⁃1098. DOI: 10.1126/science.8066448.
|
[7] |
Gok F, Ugur Y, Ozen S, et al. Pathogenesis⁃related adhesion molecules in Henoch⁃Schonlein vasculitis[J]. Rheumatol Int, 2008, 28(4): 313⁃316. DOI: 10.1007/s00296⁃007⁃0437⁃z.
|
[8] |
Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: pathogenesis and treatment of ANCA⁃associated vasculitides[J]. Nat Clin Pract Rheumatol, 2006, 2(12): 661⁃670. DOI: 10.1038/ncprheum0355.
|
[9] |
Grossetête B, Launay P, Lehuen A,et al. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA[J]. Kidney Int, 1998, 53(5): 1321⁃1335. DOI: 10.1046/j.1523⁃1755.1998.00885.x.
|
[10] |
Roccatello D, Picciotto G, Torchio M, et al. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialogly⁃coprotein receptors[J]. Lab Invest, 1993, 69(6): 714⁃723.
|
[11] |
Aleyd E, Heineke MH, van Egmond M. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease[J]. Immunol Rev, 2015, 268(1): 123⁃138. DOI: 10.1111/imr.12337.
|
[12] |
Bakema JE, van Egmond M. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity[J].Mucosal Immunol, 2011, 4(6): 612⁃624. DOI: 10.1038/mi.2011. 36.
|
[13] |
Blank U, Launay P, Benhamou M, et al. Inhibitory ITAMs as novel regulators of immunity[J]. Immunol Rev, 2009, 232(1): 59⁃71. DOI: 10.1111/j.1600⁃065X.2009.00832.x.
|
[14] |
Heineke MH, van Egmond M. Immunoglobulin A: magic bullet or Trojan horse?[J]. Eur J Clin Invest, 2017, 47(2): 184⁃192. DOI: 10.1111/eci.12716.
|
[15] |
Pitanga TN, de Aragão França L, Rocha VC, et al. Neutrophil⁃derived microparticles induce myeloperoxidase⁃mediated damage of vascular endothelial cells[J]. BMC Cell Biol, 2014, 15: 21. DOI: 10.1186/1471⁃2121⁃15⁃21.
|
[16] |
Bergin DA, Reeves EP, Meleady P, et al. α⁃1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL⁃8[J]. J Clin Invest, 2010, 120(12): 4236⁃4250. DOI: 10.1172/JCI41196.
|
[17] |
Yang YH, Lai HJ, Huang CM, et al. Sera from children with active Henoch⁃Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells[J]. Ann Rheum Dis, 2004, 63(11): 1511⁃1513. DOI: 10.1136/ard. 2003.016196.
|